97 related articles for article (PubMed ID: 1424509)
1. The activity of metal compounds against aerobic and anaerobic bacteria.
Chin N; Neu HC
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):549-52. PubMed ID: 1424509
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial activity of the new antibiotic vermisporin.
Chin NX; Neu HC
Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):755-7. PubMed ID: 1425739
[TBL] [Abstract][Full Text] [Related]
3. Susceptibilities of bovine summer mastitis bacteria to antimicrobial agents.
Jousimies-Somer H; Pyörälä S; Kanervo A
Antimicrob Agents Chemother; 1996 Jan; 40(1):157-60. PubMed ID: 8787898
[TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006].
Yamaguchi T; Yoshida I; Itoh Y; Tachibana M; Takahashi C; Kaku M; Kanemitsu K; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Baba H; Matsuo S; Asari S; Toyokawa M; Matsuoka K; Kusano N; Nose M; Murase M; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
Jpn J Antibiot; 2010 Dec; 63(6):431-56. PubMed ID: 21425596
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility of bacteria isolated from clinical material to ciprofloxacin].
Namysł E; Galiński J; Szponar M; Piechowicz L
Med Dosw Mikrobiol; 1995; 47(1-2):5-9. PubMed ID: 8523970
[TBL] [Abstract][Full Text] [Related]
6. A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.
Fernandes PB; Chu DT; Swanson RN; Ramer NR; Hanson CW; Bower RR; Stamm JM; Hardy DJ
Antimicrob Agents Chemother; 1988 Jan; 32(1):27-32. PubMed ID: 3348609
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008].
Yoshida I; Yamaguchi T; Kudo R; Fuji R; Takahashi C; Oota R; Kaku M; Kunishima H; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Fujita S; Matsuo S; Kono H; Asari S; Toyokawa M; Kusano N; Nose M; Horii T; Tanimoto A; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
Jpn J Antibiot; 2012 Feb; 65(1):49-72. PubMed ID: 22808693
[TBL] [Abstract][Full Text] [Related]
8. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1984 Mar; 25(3):319-26. PubMed ID: 6232895
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
[TBL] [Abstract][Full Text] [Related]
11. [Comparative in vitro activity of ertapenem against aerobic and anaerobic bacteria].
Loza E; Morosini MI; Cantón R; Almaraz F; Reig M; Baquero F
Rev Esp Quimioter; 2003 Jun; 16(2):209-15. PubMed ID: 12973459
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of LY146032 (daptomycin), a new peptolide.
Ehlert F; Neu HC
Eur J Clin Microbiol; 1987 Feb; 6(1):84-90. PubMed ID: 3032611
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial properties of pexiganan, an analog of magainin.
Ge Y; MacDonald DL; Holroyd KJ; Thornsberry C; Wexler H; Zasloff M
Antimicrob Agents Chemother; 1999 Apr; 43(4):782-8. PubMed ID: 10103181
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of MDL 62,879 (GE2270 A) against aerobic gram-positive and anaerobic bacteria.
King A; Bethune L; Phillips I
Antimicrob Agents Chemother; 1993 Apr; 37(4):746-9. PubMed ID: 8494370
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of A-16686, a new glycopeptide.
Neu HC; Neu NM
Chemotherapy; 1986; 32(5):453-7. PubMed ID: 3757587
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms.
Dubreuil L; Houcke I; Mouton Y; Rossignol JF
Antimicrob Agents Chemother; 1996 Oct; 40(10):2266-70. PubMed ID: 8891127
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of MC-352, a new 16-membered macrolide.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1992 Aug; 36(8):1699-702. PubMed ID: 1416853
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of the new glycopeptide decaplanin.
Neu HC; Chin NX; Niu WW
Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562
[TBL] [Abstract][Full Text] [Related]
19. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
Barlam T; Neu HC
Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
